Arca
Skip to content

P2RY12: P2Y purinoceptor 12

A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.

Receptor for ADP and ATP coupled to G proteins that inhibit the adenylyl cyclase second messenger system.

  • Drugs that act on it: 8
  • With a US drug page: 4
  • Type: Protein

Drugs That Act on It

Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page
CangrelorApprovedPurinergic receptor P2Y12 antagonistAntagonist—
PrasugrelApprovedPurinergic receptor P2Y12 antagonistAntagonistBoxed warning
TicagrelorApprovedPurinergic receptor P2Y12 negative allosteric modulatorNegative allosteric modulatorBoxed warning
TiclopidineApprovedPurinergic receptor P2Y12 antagonistAntagonistBoxed warning
Clopidogrel—Purinergic receptor P2Y12 antagonistAntagonistBoxed warning
Elinogrel—Purinergic receptor P2Y12 antagonistAntagonist—
Regrelor—Purinergic receptor P2Y12 antagonistAntagonist—
Selatogrel—Purinergic receptor P2Y12 antagonistAntagonist—

Diseases Most Associated With It

Open Targets association score, 0 to 1; all associations
Platelet-type bleeding disorder 8
0.73
Stroke disorder
0.61
Coronary artery disorder
0.60
Peripheral vascular disease
0.60
Angina unstable
0.57
Recurrent thrombophlebitis
0.55
Thrombotic disease
0.54

Drugs and mechanisms are from ChEMBL CHEMBL2001 (CC BY-SA 3.0). Gene name, function (UniProt Q9H244, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.